See more : United American Healthcare Corporation (UAHC) Income Statement Analysis – Financial Results
Complete financial analysis of Skylight Health Group Inc. (SLHPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Skylight Health Group Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Avante Logixx Inc. (ALXXF) Income Statement Analysis – Financial Results
- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (VOLARA.MX) Income Statement Analysis – Financial Results
- Grainger plc (GRGTF) Income Statement Analysis – Financial Results
- Raisio plc (RAIVV.HE) Income Statement Analysis – Financial Results
- SCI Engineered Materials, Inc. (SCIA) Income Statement Analysis – Financial Results
Skylight Health Group Inc. (SLHPF)
About Skylight Health Group Inc.
Skylight Health Group Inc. operates as a healthcare services and technology company in the United States, Canada, the United Kingdom, and Colombia. It operates the US multi-state primary care health network, which provides a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The company also owns and operates a proprietary electronic health record system that supports the delivery of care to patients through telemedicine and other remote monitoring system integrations. In addition, it offers a disruptive subscription-based telemedicine service for the un/under-insured population. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Revenue | 0.00 | 27.16M | 13.14M | 13.42M | 0.00 |
Cost of Revenue | 0.00 | 12.07M | 4.11M | 4.10M | 0.00 |
Gross Profit | 0.00 | 15.09M | 9.03M | 9.32M | 0.00 |
Gross Profit Ratio | 0.00% | 55.55% | 68.71% | 69.45% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 28.89M | 13.13M | 11.68M | 218.28K |
Selling & Marketing | 0.00 | 2.04M | 626.35K | 1.06M | 0.00 |
SG&A | 0.00 | 30.93M | 13.76M | 12.74M | 218.28K |
Other Expenses | 0.00 | 956.00K | -2.18M | 0.00 | 0.00 |
Operating Expenses | 0.00 | 35.54M | 16.08M | 15.00M | 218.28K |
Cost & Expenses | 0.00 | 47.62M | 20.20M | 19.10M | 218.28K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 964.00K | 166.20K | 240.95K | 0.00 |
Depreciation & Amortization | 228.49K | 4.62M | 1.09M | 2.26M | 161.14K |
EBITDA | 0.00 | -16.22M | -4.73M | -3.42M | -2.45K |
EBITDA Ratio | 0.00% | -54.81% | -35.99% | -25.47% | 0.00% |
Operating Income | 0.00 | -21.87M | -7.05M | -9.28M | -218.28K |
Operating Income Ratio | 0.00% | -80.52% | -53.68% | -69.17% | 0.00% |
Total Other Income/Expenses | 0.00 | -285.00K | -2.43M | -1.58M | 0.00 |
Income Before Tax | 0.00 | -22.15M | -9.48M | -10.86M | -218.28K |
Income Before Tax Ratio | 0.00% | -81.57% | -72.15% | -80.92% | 0.00% |
Income Tax Expense | 0.00 | -6.48M | 166.20K | 111.51K | -161.14K |
Net Income | 0.00 | -13.75M | -9.48M | -10.97M | -218.28K |
Net Income Ratio | 0.00% | -50.62% | -72.15% | -81.75% | 0.00% |
EPS | 0.00 | -0.37 | -0.43 | -0.71 | -0.02 |
EPS Diluted | 0.00 | -0.37 | -0.43 | -0.71 | -0.02 |
Weighted Avg Shares Out | 0.00 | 37.45M | 21.88M | 15.44M | 14.03M |
Weighted Avg Shares Out (Dil) | 0.00 | 37.45M | 21.88M | 15.44M | 14.03M |
Source: https://incomestatements.info
Category: Stock Reports